BETHESDA, Md., Sept. 3, 2019 /PRNewswire/ -- Healthy Directions LLC, a subsidiary of Adaptive Health, LLC, is proud to announce its newly signed partnership with Dr. Briana Sinatra, a practicing, board-certified naturopathic physician with a focus on women's and family health and wellness. 

ROSEMONT, Ill., Sept. 3, 2019 /PRNewswire/ -- With one internet search, a patient can find a host of information and marketing materials touting the purported benefits of laser surgery. Since 2011 "laser spine surgery" has become more popular among Google search terms than widely accepted spine techniques such as "minimally invasive spine surgery" or "artificial disk rep

ATLANTA and DALLAS, Sept. 3, 2019 /PRNewswire/ -- Axxess, the leading home healthcare technology company, and Trella Health, a leading source for post-acute performance analytics and outcomes data, have partnered to provide Axxess customers improved benchmark quality performance metrics while strengthening referral relationships to a

PITTSBURGH, Sept. 3, 2019 /PRNewswire/ -- The Hematology/Oncology Pharmacy Association and Oncology Nursing Society have partnered to develop a joint position statement in advance of an upcoming compliance deadline for U.S. Pharmacopeia Chapter 800 (USP <800>).

PHOENIX, Sept. 3, 2019 /PRNewswire/ -- A Phoenix-based technology expert and a behavioral health advocate have launched a digital health management platform designed to promote positive and sustainable outcomes for patients while increasing revenues for providers.

BROOMFIELD, Colo., Sept. 3, 2019 /PRNewswire/ -- SCL Health continues to build on its commitment to person-centered care and transforming the patient experience through innovative and

BETHESDA, Md., Sept. 3, 2019 /PRNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) announces that Maximilian Muenke, MD, FACMG will become its new CEO, following a thorough national search.

SEATTLE, Sept. 3, 2019 /PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced the last patient has been enrolled in "STOP-301" (Safety and Tol

SANTA ANA, Calif., Sept. 3, 2019 /PRNewswire/ -- Kelly Williams of Fullerton, a direct support professional who was honored with a Regional Center

KRAKOW, Poland, Sept. 3, 2019 /PRNewswire/ -- Selvita (WSE: SLV) a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that the Polish Financial Supervision Authority has approved the prospectus of Selvita CRO, a requ